Femasys (FEMY) Non Operating Income (2020 - 2025)
Femasys posted quarterly Non Operating Income of -$260000.0 for Q2 2025, down 27.34% year-on-year from -$357845.7 in Q2 2024, and up 40.97% on a QoQ basis from -$440420.0 in Q1 2025.
Femasys (FEMY) has 6 years of Non Operating Income data on file, last reported at -$260000.0 in Q2 2025.
- For the quarter ending Q2 2025, Non Operating Income fell 27.34% year-over-year to -$260000.0; the trailing twelve-month figure through Jun 2025 stood at -$359379.0 (down 68.5% YoY), and the FY2025 full-year result was -$482562.0, changed N/A from the prior year.
- Non Operating Income for Q2 2025 stood at -$260000.0, up from -$440420.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $818016.0 in Q2 2021 and bottomed at -$440420.0 in Q1 2025.
- The 5-year median for Non Operating Income is $25862.0 (2022), against an average of $34367.4.
- The widest annual swing landed in 2021, when Non Operating Income surged 45095.38%; it then plunged 580.93% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$3117.0 in 2021, then jumped by 3708.15% to $112466.0 in 2022, then slumped by 61.41% to $43399.0 in 2023, then soared by 1352.34% to $630303.0 in 2024, then sank by 141.25% to -$260000.0 in 2025.
- The last three Non Operating Income figures came in at -$260000.0 (Q2 2025), -$440420.0 (Q1 2025), and $630303.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 85.10 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 86.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -1.37 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -200,000.00 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -4.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 1.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 3.02 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -6.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -53,000.00 |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -260,000.00 |
| Mar 31, 2025 | -440,420.00 |
| Dec 31, 2024 | 630,303.00 |
| Sep 30, 2024 | -289,262.00 |
| Jun 30, 2024 | -204,173.00 |
| Mar 31, 2024 | -136,868.00 |
| Dec 31, 2023 | 43,399.00 |
| Sep 30, 2023 | 84,359.00 |
| Jun 30, 2023 | 42,454.00 |
| Mar 31, 2023 | 95,417.00 |
| Dec 31, 2022 | 112,466.00 |
| Sep 30, 2022 | 74,346.00 |
| Jun 30, 2022 | 25,862.00 |
| Mar 31, 2022 | -280.00 |
| Dec 31, 2021 | -3,117.00 |
| Sep 30, 2021 | -8,256.00 |
| Jun 30, 2021 | 818,016.00 |
| Dec 31, 2020 | 6,746.00 |
| Sep 30, 2020 | -3,418.00 |
| Jun 30, 2020 | -1,818.00 |